Medtronic, Parkinson's and FDA
Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease
Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs
Shares of Medtronic PLC MDT rallied 1.41% to $92.02 Friday, on what proved to be an all-around great trading session for the ...
Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...
Medtronic announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB) ...
Medtronic (NYSE:MDT), which has operations worldwide, is reportedly looking at adjusting its manufacturing footprint amid ...
10don MSN
Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...
Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
The revenue miss came as sales at Medtronic's Medical Surgical division declined 1.9% to $2.07 billion. The company pointed ...
Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback